Global Health Limited Business Intelligence Report
Global Health Limited Business Intelligence Report
Quality Scores
Latest Quarterly Earnings Summary
Loading latest quarter…
AI Summary
Global Health Limited (Medanta) has established itself as a premier multi-specialty tertiary care provider in North and East India, demonstrating a significant turnaround from FY21 onwards. The company operates 3,435 installed beds across 6 hospitals, with a specialty focus on high-complexity clinical disciplines. Revenue has grown at a 25% CAGR over the last 5 years, while trailing profits have surged at 81% CAGR due to operating leverage and improving occupancy. The business profile is characterized by high Average Revenue Per Occupied Bed (ARPOB) and a premium clinical talent pool. Current…
Key Changes in FY2026
Medanta has evolved from a single-flagship specialty center in Gurugram (established 2009) into a multi-city tertiary healthcare network. The evolution is marked by a shift towards a hub-and-spoke model and expansion into underserved regions like Bihar (Patna) and Uttar Pradesh (Lucknow, Noida). The clinical profile has deepened into high-acuity specialties including organ transplants and robotic surgeries, which command higher Average Revenue Per Occupied Bed (ARPOB). Between 2016 and 2026, the company nearly tripled its revenue from ₹1,382 Cr to ₹4,410 Cr, demonstrating a successful scaling of the Medanta brand. Digital transformation initiatives via the 'Medanta eClinic' and lab expansion signify a move towards an integrated healthcare ecosystem. The business is successfully moving up…
Management Commentary
Led by Dr. Naresh Trehan, a globally renowned cardiac surgeon, the leadership combines high-level clinical excellence with professional corporate management. The vision centers on 'cluster-based' dominance, ensuring Medanta remains the primary referral center for complex cases. MD&A commentary is consistently transparent regarding expansion timelines and clinical outcome benchmarks. There is a clear focus on digital transformation and home care to extend the hospital ecosystem. Management has successfully navigated the transition from a private-equity-backed entity to a listed corporation without significant governance friction.
Financial Highlights
The financial trajectory of Medanta shows a clear inflection point in FY22, where margins expanded from mid-teens to over 20%. Revenue grew from ₹1,447 Cr in FY21 to ₹4,410 Cr (Expected 2026), driven by the scaling of the Lucknow and Patna units. EBITDA margins reached a peak of 25% in FY24 before cooling slightly due to new expansion costs in Noida and Lucknow phase II. Return on Equity (ROE) has stabilized at 15-16% following the IPO-led deleveraging. Interest coverage remains healthy as the company utilizes internal accruals to fund brownfield expansions.
Major Opportunities
- Exceptional 5-year PAT CAGR of 81%
- Consistent negative Cash Conversion Cycle
- Robust ROCE of 17-20%
Major Risks
- Stock price trading at expensive 8.5x Book Value
- Heavy concentration in North and East India
- Recent margin contraction in FY26 projections
About Global Health Limited's Annual Report & Financial Performance
The latest Global Health Limited annual report (FY2026) is the company's flagship annual disclosure, filed with NSE / BSE. It covers the full-year business review, management discussion & analysis, audited financial statements, the director's report, the corporate governance and auditor's reports, risk factors, capital allocation, subsidiaries, related-party transactions and ESG initiatives. This Business Intelligence Hub consolidates the official filings with AI-generated financial analysis so investors can see how revenue, operating margin, cash flow quality, capex, dividends, net debt and management outlook have changed — without reading the entire filing.
What this Global Health Limited research covers
- Fundamental & business analysis
- Financial statements & performance
- Management commentary & discussion
- Corporate governance & auditor report
- Cash flow analysis & capital allocation
- Valuation analysis & business quality
- Growth analysis & competitive position
- Risk, SWOT & moat analysis
- Quarterly earnings & conference-call summary
- Sector, industry & peer comparison
- Latest official company filings
- Business outlook & long-term growth
Global Health Limited — Frequently Asked Questions
Explore more Global Health Limited research
AI Top Insights — Premium
Unlock deeper AI Top Insights, advanced comparisons, downloadable reports and premium features.